Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72

Identifieur interne : 002B52 ( Main/Exploration ); précédent : 002B51; suivant : 002B53

Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72

Auteurs : F. A. Ennis ; M. A. Wells ; D. W. Barry ; S. Daniel ; J. Manischewitz

Source :

RBID : ISTEX:0F8F4F8B4496010525F0FEB83231198C23A3879A

English descriptors

Abstract

Influenza virus strains A2/Port Chalmers/1/73 (H3N2) and B/Hong Kong/5/72 were adapted to mice by serial passage of virus infected mouse lungs. The adapted viruses were used to challenge mice after they had been immunized with serial dilutions of several bivalent vaccines, containing both A/Port Chalmers and B/Hong Kong antigens. Vaccines included both whole virus and split-product preparations disrupted by Tween 80 and ether (ET) or tri-N-butyl phosphate (TBP). These bivalent vaccines induced antibodies and conferred protection to mice against challenge with approximately 30 LD50 of the adapted A2/Port Chalmers virus. Significant protection against lethality (P<0·01) was observed in groups of mice which developed haemagglutinin-inhibition antibody titres of ≥1:16 following immunization. Protection was not statistically significant in groups of mice which developed antibody titres of ≤1:8 to the A/Port Chalmers/1/73 virus following immunization with higher dilutions of certain vaccines. In a similar fashion, current bivalent vaccines containing B/Hong Kong/5/72 stimulated antibodies and conferred significant protection to immunized mice against lethal challenge with the adapted B/Hong Kong virus. Protection was demonstrated against approximately 30 LD50 of adapted virus in groups of mice which developed mean antibodies of ≥1:16. Groups of mice, which developed antibody titres of <1:8 following immunization with certain dilutions of these vaccines, were not significantly protected. These studies confirm and extend observations made with formerly circulating influenza viruses, i.e. immunization with a specific inactivated vaccine in adequate dosage confers protection against a challenge dose of virus lethal to unimmunized mice.

Url:
DOI: 10.1136/pgmj.52.608.338


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72</title>
<author>
<name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F. A." last="Ennis">F. A. Ennis</name>
</author>
<author>
<name sortKey="Wells, M A" sort="Wells, M A" uniqKey="Wells M" first="M. A." last="Wells">M. A. Wells</name>
</author>
<author>
<name sortKey="Barry, D W" sort="Barry, D W" uniqKey="Barry D" first="D. W." last="Barry">D. W. Barry</name>
</author>
<author>
<name sortKey="Daniel, S" sort="Daniel, S" uniqKey="Daniel S" first="S." last="Daniel">S. Daniel</name>
</author>
<author>
<name sortKey="Manischewitz, J" sort="Manischewitz, J" uniqKey="Manischewitz J" first="J." last="Manischewitz">J. Manischewitz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0F8F4F8B4496010525F0FEB83231198C23A3879A</idno>
<date when="1976" year="1976">1976</date>
<idno type="doi">10.1136/pgmj.52.608.338</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-GV89HQTS-6/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000592</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000592</idno>
<idno type="wicri:Area/Istex/Curation">000592</idno>
<idno type="wicri:Area/Istex/Checkpoint">001719</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001719</idno>
<idno type="wicri:doubleKey">0032-5473:1976:Ennis F:host:defence:mechanisms</idno>
<idno type="wicri:Area/Main/Merge">002D22</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496327</idno>
<idno type="RBID">PMC:2496327</idno>
<idno type="wicri:Area/Pmc/Corpus">000435</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000435</idno>
<idno type="wicri:Area/Pmc/Curation">000435</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000435</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000E19</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000E19</idno>
<idno type="wicri:Area/Ncbi/Merge">001364</idno>
<idno type="wicri:Area/Ncbi/Curation">001364</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001364</idno>
<idno type="wicri:doubleKey">0032-5473:1976:Ennis F:host:defence:mechanisms</idno>
<idno type="wicri:Area/Main/Merge">002C74</idno>
<idno type="wicri:Area/Main/Curation">002B52</idno>
<idno type="wicri:Area/Main/Exploration">002B52</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72</title>
<author>
<name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F. A." last="Ennis">F. A. Ennis</name>
</author>
<author>
<name sortKey="Wells, M A" sort="Wells, M A" uniqKey="Wells M" first="M. A." last="Wells">M. A. Wells</name>
</author>
<author>
<name sortKey="Barry, D W" sort="Barry, D W" uniqKey="Barry D" first="D. W." last="Barry">D. W. Barry</name>
</author>
<author>
<name sortKey="Daniel, S" sort="Daniel, S" uniqKey="Daniel S" first="S." last="Daniel">S. Daniel</name>
</author>
<author>
<name sortKey="Manischewitz, J" sort="Manischewitz, J" uniqKey="Manischewitz J" first="J." last="Manischewitz">J. Manischewitz</name>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Postgraduate Medical Journal</title>
<title level="j" type="abbrev">Postgrad Med J</title>
<idno type="ISSN">0032-5473</idno>
<idno type="eISSN">1469-0756</idno>
<imprint>
<publisher>The Fellowship of Postgraduate Medicine</publisher>
<date type="published" when="1976-06">1976-06</date>
<biblScope unit="volume">52</biblScope>
<biblScope unit="issue">608</biblScope>
<biblScope unit="page" from="338">338</biblScope>
</imprint>
<idno type="ISSN">0032-5473</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0032-5473</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Antibody</term>
<term>Antibody response</term>
<term>Antibody titres</term>
<term>Challenge dose</term>
<term>Challenge virus</term>
<term>Chalmers</term>
<term>Chalmers virus</term>
<term>Control mice</term>
<term>Cpwv</term>
<term>Dilution</term>
<term>Experimental biology</term>
<term>Haemagglutination inhibition antibodies</term>
<term>Higher dilutions</term>
<term>Highest challenge dose</term>
<term>Immune response</term>
<term>Immunization</term>
<term>Individual sera</term>
<term>Influenza</term>
<term>Influenza infection</term>
<term>Influenza vaccines</term>
<term>Influenza virus</term>
<term>Influenza viruses</term>
<term>Kong antigen</term>
<term>Less immunogenic</term>
<term>Lethal challenge</term>
<term>Lower levels</term>
<term>Mouse</term>
<term>Mouse model</term>
<term>Natural exposure</term>
<term>Other vaccines</term>
<term>Same bivalent vaccines</term>
<term>Serial dilutions</term>
<term>Serial passage</term>
<term>Serum antibody</term>
<term>Significant protection</term>
<term>Specific protection</term>
<term>Splitproduct vaccines</term>
<term>Standard deviation</term>
<term>Statistical significance</term>
<term>Subsequent challenge</term>
<term>Titre</term>
<term>Vaccinated animals</term>
<term>Vaccine</term>
<term>Vaccine dilution</term>
<term>Virion</term>
<term>Virus</term>
<term>Virus challenge</term>
<term>Whole virion</term>
<term>Whole virus</term>
<term>Whole virus vaccine</term>
<term>Whole virus vaccines</term>
<term>Young children</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Influenza virus strains A2/Port Chalmers/1/73 (H3N2) and B/Hong Kong/5/72 were adapted to mice by serial passage of virus infected mouse lungs. The adapted viruses were used to challenge mice after they had been immunized with serial dilutions of several bivalent vaccines, containing both A/Port Chalmers and B/Hong Kong antigens. Vaccines included both whole virus and split-product preparations disrupted by Tween 80 and ether (ET) or tri-N-butyl phosphate (TBP). These bivalent vaccines induced antibodies and conferred protection to mice against challenge with approximately 30 LD50 of the adapted A2/Port Chalmers virus. Significant protection against lethality (P<0·01) was observed in groups of mice which developed haemagglutinin-inhibition antibody titres of ≥1:16 following immunization. Protection was not statistically significant in groups of mice which developed antibody titres of ≤1:8 to the A/Port Chalmers/1/73 virus following immunization with higher dilutions of certain vaccines. In a similar fashion, current bivalent vaccines containing B/Hong Kong/5/72 stimulated antibodies and conferred significant protection to immunized mice against lethal challenge with the adapted B/Hong Kong virus. Protection was demonstrated against approximately 30 LD50 of adapted virus in groups of mice which developed mean antibodies of ≥1:16. Groups of mice, which developed antibody titres of <1:8 following immunization with certain dilutions of these vaccines, were not significantly protected. These studies confirm and extend observations made with formerly circulating influenza viruses, i.e. immunization with a specific inactivated vaccine in adequate dosage confers protection against a challenge dose of virus lethal to unimmunized mice.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Barry, D W" sort="Barry, D W" uniqKey="Barry D" first="D. W." last="Barry">D. W. Barry</name>
<name sortKey="Daniel, S" sort="Daniel, S" uniqKey="Daniel S" first="S." last="Daniel">S. Daniel</name>
<name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F. A." last="Ennis">F. A. Ennis</name>
<name sortKey="Manischewitz, J" sort="Manischewitz, J" uniqKey="Manischewitz J" first="J." last="Manischewitz">J. Manischewitz</name>
<name sortKey="Wells, M A" sort="Wells, M A" uniqKey="Wells M" first="M. A." last="Wells">M. A. Wells</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B52 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B52 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:0F8F4F8B4496010525F0FEB83231198C23A3879A
   |texte=   Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021